Two Sigma Investments
CURX

Two Sigma Investments’s Curanex Pharmaceuticals CURX Stock Holding History

Two Sigma Investments’s Portfolio CURX Stock Details CURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.4K Sell
20,254
-40,848
-67% -$15.3K ﹤0.01% 4529
2025
Q4 		$20.2K Buy
+61,102
New +$33.6K ﹤0.01% 3998

Other funds holding CURX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Investments's CURX Position: Q1 2026 in Review

Two Sigma Investments reduced its Curanex Pharmaceuticals (CURX) stake by 67% in Q1 2026, selling an estimated $15.3K and leaving 20,254 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4529.

Two Sigma Investments first reported a position in CURX in Q4 2025 and has held it in 2 quarters since. The position peaked at $20.2K in Q4 2025. 8 funds tracked by Wall St. Rank hold CURX as of Q1 2026.

  • Two Sigma Investments held 20,254 shares of Curanex Pharmaceuticals worth $10.4K as of Q1 2026.
  • Two Sigma Investments sold 40,848 Curanex Pharmaceuticals shares in Q1 2026, an estimated $15.3K.
  • Curanex Pharmaceuticals made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #4529 holding.
  • Two Sigma Investments first reported a position in Curanex Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Two Sigma Investments's Curanex Pharmaceuticals position peaked at $20.2K in Q4 2025.
  • 8 funds tracked by Wall St. Rank held Curanex Pharmaceuticals as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.